Testimony in Opposition to SB 2744 (AI Cardiovascular Screening Mandate) 4.30.25
TAHP opposes Senate Bill 2744, which would mandate coverage and a fixed minimum payment for a new artificial intelligence-based cardiovascular screening that lacks strong scientific evidence for routine use in asymptomatic patients. This bill sets a dangerous precedent by requiring employer health plans to cover an emerging, high-cost technology before it has been fully validated by the U.S. Preventive Services Task Force. SB 2744 also imposes a $2,000 minimum reimbursement rate—double Medicare’s typical payment—further driving up costs for employers and families in an already unaffordable health care landscape.
Click here to view TAHP’s testimony in response to SB 2744.
